5111-13-7

Upstream product

• 14362-29-9 α-D-glucurono-γ-lactone 
• 100-39-0 benzyl bromide 
• 3067-56-9 D-glucurono-3,6-lactone acetonide 
• 81927-55-1 O-benzyl 2,2,2-trichloroacetimidate 

Downstream Products

• 5111-14-8 1,2-O-isopropylidene-5-O-benzyl-3-hydroxy-α-D-glucofuranosiduronamide 
• 133634-85-2 3,6-anhydro-5-O-benzyl-1,2-O-isopropylidene-6-C-methylene-α-D-glucofuranose 
• 94686-95-0 5,6-Di-O-benzyl-D-glucofuranose 
• 1394245-89-6 C₂₀H₂₂O₆ 
• 1394245-87-4 C₂₅H₃₂O₇ 
• 1394245-86-3 C₂₄H₄₀O₇Si 
• 142719-12-8 C₂₂H₃₆O₆Si 
• 1394245-99-8 (5S)-epi-vittarilide A 
• 1394245-94-3 C₃₉H₇₂O₉Si₄ 
• 1394245-92-1 C₂₀H₂₂O₆ 
• 1394245-97-6 C₂₅H₃₂O₇ 
• 864512-90-3 trans-caffeoyl-6-O-D-glucono-γ-lactone 
• 1394245-90-9 C₃₉H₇₂O₉Si₄ 

Relevant academic research and scientific papers

Synthesis of 1,3,4,6-Tetra-O-acetyl-l-gulose

A novel, practical and concise synthesis of 1,3,4,6-tetra-O-acetyl-l-gulose is described, using d-glucuronolactone as the starting material and other inexpensive and readily available agents (22% overall yield in 9 steps). With this method, the synthesis of l-gulose and the tumor-targeting disaccharide of BLMs can be more efficient and convenient.

Stereodivergent synthesis of new amino sugars, furanodictines A and B, starting from d-glucuronolactone

An efficient and divergent strategy for the total synthesis of the first 3,6-dihydroaminosugars, furanodictines A (2-acetamido-3,6-anhydro-2-deoxy-5-O-isovaleryl-d-glucofuranose) and B (2-acetamido-3,6-anhydro-2-deoxy-5-O-isovaleryl-d-mannofuranose), has been developed. The synthetic process is featured by readily accessible and stereodefined manipulation of highly functionalized bicyclic tetrahydrofuran derivatives incorporating the glucuronolactone (common starting material)-derived skeleton.

An efficient and straightforward synthetic process to an amino sugar analogue, furanodictine B

A convenient and practical strategy for the construction of a natural amino sugar analogue, furanodictine B, isolated from the multicellular fruit body has been developed in an optically active form. The synthetic process is based on readily accessible and stereodefmed manipulation of the highly functionalized bicyclic derivative incorporating the glucuronolactone-derived skeleton.

Acceptor site recognition of transglycosylase inhibitors A β-D- glucopyranosyl-(1 → 2)-α-D-glucopyranuronamide-derived moenomycin analogue

The synthesis, the antibiotic and the transglycosylase inhibiting properties of a disaccharide analogue of moenomycin A in which the NHAc group of unit E is replaced by a hydroxyl function are described. It can be concluded that this NHAc group is essenti